tiprankstipranks
Conduit Pharmaceuticals (CDT)
NASDAQ:CDT
US Market
Holding CDT?
Track your performance easily

Conduit Pharmaceuticals (CDT) Financial Statements

190 Followers

Conduit Pharmaceuticals Financial Overview

Conduit Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.21; its P/E ratio is -0.35; Conduit Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -6.41M$ -5.34M$ 2.48M$ 2.11M$ 2.03M
EBITDA$ -5.83M$ -4.90M$ 2.90M$ 2.11M$ 2.03M
Net Income Common Stockholders$ -6.46M$ -5.38M$ -3.60M$ -1.89M$ 1.99M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 152.00K$ 414.00K$ 1.84M$ 4.23M$ 8.64M
Total Assets$ 2.99M$ 3.31M$ 4.92M$ 7.22M$ 12.02M
Total Debt$ 2.67M$ 1.27M$ 495.00K$ 185.00K$ 177.00K
Net Debt$ 2.51M$ 854.00K$ -1.35M$ -4.04M$ -8.47M
Total Liabilities$ 12.11M$ 8.77M$ 8.02M$ 7.68M$ 13.10M
Stockholders Equity$ -9.12M$ -5.46M$ -3.10M$ -457.00K$ -1.08M
Cash Flow-
Free Cash Flow$ -2.04M$ -1.51M$ -2.40M$ -4.80M$ -1.68M
Operating Cash Flow$ -2.00M$ -1.50M$ -2.40M$ -4.80M$ -1.68M
Investing Cash Flow$ 96.00K$ -224.00K-$ 497.00K$ -114.24M
Financing Cash Flow$ 1.74M$ 113.00K-$ -414.00K$ 124.66M
Currency in USD

Conduit Pharmaceuticals Earnings and Revenue History

Conduit Pharmaceuticals Debt to Assets

Conduit Pharmaceuticals Cash Flow

Conduit Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis